These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18426787)

  • 1. Guidelines improve general trend of lowered cholesterol levels in type 2 diabetes patients in spite of low adherence.
    Fhärm E; Rolandsson O; Weinehall L
    Scand J Public Health; 2008 Jan; 36(1):69-75. PubMed ID: 18426787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of dyslipidaemia and improvement in its management in England: results from the Health Survey for England 2003.
    Primatesta P; Poulter NR
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):292-8. PubMed ID: 16487439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for new American Diabetes Association Guidelines: are national cholesterol education program goals adequate for the patient with diabetes mellitus?
    Haffner S
    Am J Cardiol; 2005 Aug; 96(4A):33E-36E. PubMed ID: 16098841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of type 2 diabetes mellitus: is it in accordance with the guidelines?
    Chan GC; Ghazali O; Khoo EM
    Med J Malaysia; 2005 Dec; 60(5):578-84. PubMed ID: 16515108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inadequate treatment of dyslipidemia in people with type 2 diabetes: quality assessment of diabetes care in a Danish County.
    Kolding Kristensen J; Lauritzen T
    Scand J Prim Health Care; 2006 Sep; 24(3):181-5. PubMed ID: 16923628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice.
    van Bruggen R; Gorter K; Stolk RP; Zuithoff P; Klungel OH; Rutten GE
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):983-91. PubMed ID: 19623570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of lipid-lowering treatment according to lipid level.
    Pilote L; Ho V; Lavoie F; Coupal L; Zowall H; Grover SA
    Can J Cardiol; 2005 Jun; 21(8):681-7. PubMed ID: 16003451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of physicians' beliefs and practices on cholesterol levels in patients with type 2 diabetes: a longitudinal assessment.
    Franciosi M; Pellegrini F; De Berardis G; Belfiglio M; Di Nardo B; Greenfield S; Kaplan SH; Rossi MC; Sacco M; Tognoni G; Valentini M; Nicolucci A;
    Am Heart J; 2005 Jan; 149(1):104-11. PubMed ID: 15660041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
    Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
    J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease.
    Koga H; Sugiyama S; Kugiyama K; Fukushima H; Watanabe K; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
    Eur Heart J; 2006 Apr; 27(7):817-23. PubMed ID: 16434416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study.
    Eliasson M; Janlert U; Jansson JH; Stegmayr B
    J Intern Med; 2006 Dec; 260(6):551-9. PubMed ID: 17116006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Implementation of clinical guidelines in general practice. The effect of journal audit and continuing education for the treatment of cardiovascular risk factors in patients with and without type 2 diabetes].
    Madsbad S; Larsen ML; Adeler HF; Kryhlmand M; Westergaard M
    Ugeskr Laeger; 2006 Apr; 168(17):1640-5. PubMed ID: 16674875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in lipid-lowering treatment rates among TRICARE beneficiaries: a population-based study.
    Devine J; Linton A; Mistry H; Napier J; Trice S; Bacon T
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):891-9. PubMed ID: 19634117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States.
    Woloshin S; Schwartz LM; Kerin K; Welch HG
    J Gen Intern Med; 2007 Feb; 22(2):197-204. PubMed ID: 17356986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
    Oriol-Zerbe C; Abholz HH
    Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
    Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
    Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Degree of control of cardiovascular risk factors among a patient population with diabetes mellitus type 1 and 2].
    López-Maldonado FJ; Reza-Albarrán AA; Suárez OJ; Villa AR; Ríos-Vaca A; Gómez-Pérez FJ; Rull JA
    Gac Med Mex; 2009; 145(1):1-6. PubMed ID: 19256404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.